Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest industrial biotechnology Stories

2012-05-10 10:25:45

SAN DIEGO, May 10, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today reported operating highlights and financial results for the first quarter ended March 31, 2012. "The first quarter was a turning point for Verenium. Beyond the repayment of our outstanding debt, we also initiated discussions with a wide array of companies who recognize the value of our...

2012-05-01 21:06:04

Passage of the America Invents Act into law led to the most dramatic changes in the U.S. patent system in 60 years. These reforms will have a significant impact on technology innovators such as biotechnology-based businesses, as detailed in two articles in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc. The articles are available free online on the Industrial Biotechnology website. "Industrial biotechnology companies rely heavily on their patents to attract...

2012-04-25 10:21:20

Affiliate Group Aims to Advance Commercialization of Industrial Biotechnology WASHINGTON, April 25, 2012 /PRNewswire-USNewswire/ -- The Society of Chemical Manufacturers and Affiliates (SOCMA) today announced the launch of SCD-iBIO, a new affiliate group that aims to advance the commercialization of industrial biotechnology, which is the application of biology for the production and processing of chemicals, pharmaceuticals, materials and energy. The group is referred to by its acronym,...

2012-04-24 02:29:42

SAN DIEGO, April 24, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that the Company is a sponsor and scheduled presenter at the upcoming 2012 BIO World Congress on Industrial Biotechnology and Bioprocessing. The conference is taking place April 29 - May 2, 2012 at the Gaylord Palms Resort and Convention Center in Orlando, Florida. James Levine,...

2012-03-05 07:00:00

SAN DIEGO, March 5, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it is notifying holders of the $34,851,000 outstanding principal amount of its 5.5% Convertible Senior Notes due 2027 that it will repurchase at each holder's option on April 2, 2012 all or a portion of such holder's notes at a price equal to $1,000 per $1,000 principal amount...

2012-03-05 07:00:00

SAN DIEGO, March 5, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today reported financial results for the fourth quarter and year ended December 31, 2011. "2011 was an important year for Verenium. The growth in our product and collaborative revenues further validates the strength of our technology platform and our ability to create superior products and...

2012-02-09 23:46:12

Applying 21st century tools and technologies to manage land use, maximize biomass production, and increase the efficiency of processes for extracting energy from renewable resources will enable the biofuels industry to overcome current challenges in bioenergy production, according to a comprehensive review article published in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc. (http://www.liebertpub.com). The article is available free online at...

2011-11-10 15:00:00

SAN DIEGO, Nov. 10, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today reported a summary of recent Company highlights and financial results for the third quarter and nine months ended September 30, 2011. "We have made strong financial and operational progress in the first nine months of this year," said James E. Levine, President and Chief Executive...

2011-10-05 07:00:00

BioCee, a Minnesota-based material science and industrial biotechnology company, announced today that it has signed an asset purchase and license agreement to access certain technology from Verenium Corporation, a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, for the development of an environmentally-friendly biological method of removing sulfur from oil and oil distillates Minneapolis, Minnesota (PRWEB) October 05, 2011...

2011-10-05 13:55:00

SOUTH SAN FRANCISCO, Calif., Oct. 5, 2011 /PRNewswire/ -- A recent survey of California's pioneering industrial biotechnology sector shows that this sector has great potential for job growth in the state. California's industrial biotechnology industry increased employment by 632 percent in the past five years, according to a survey conducted by BayBio and BIOCOM, the leading biotechnology industry associations in the state, and Radford, a compensation consulting firm. California's...